"Differential Diagnosis" / Digital Health without buzz words

Home
Archive
About
New
Top
Discussion
Software and Pharma, moving beyond drug discovery
TL:DR - Is there a real opportunity for digital health companies to do more with pharma? Yes, but….
 • 
Nadav Shimoni
November 2022
Changing Buyer Landscape
Or - Why now it might be a good time to stress test your GTM hypothesis?
 • 
Nadav Shimoni
October 2022
September 2022
Digital Health Business - Dr. John Danaher, President at Adtalem Global Education, former President of Global Clinical Solutions at Elsevier…
The Education & Training market
 • 
Nadav Shimoni
2
August 2022
Did large tech finally figure out their healthcare strategy (and divide the industry between themselves?)
Jeff Bezos, Tim Cook, Mark Zuckerberg, Sundar Pichai and Satya Nadella were just heading off the back room of the small restaurant. Nothing but smiles…
 • 
Nadav Shimoni
2
July 2022
Digital Health Business – Dr. Deneen Vojta, former EVP R&D at United Health Group
New episode in Digital Health Business by Arkin Digital Health. (“Miniseries of interviews with industry leaders, coming from different parts of the US…
 • 
Nadav Shimoni
Introducing “Digital Health Business”
Dr. David Shulkin - The Ninth Secretary of the US Department of Veterans Affairs
 • 
Nadav Shimoni
June 2022
Israel and Digital Health – much more than data, and what can be learned from New York?
Much has been said about the huge potential Israel has as a digital health powerhouse. One of the most common arguments is the breadth and depth of data…
 • 
Nadav Shimoni
April 2022
The first “patient facing” digital health wave is over….
Or the customer segment that can’t be ignored any more
 • 
Nadav Shimoni
February 2022
Where is the telehealth market heading and how can the history of the EHR industry help predict it?
In the last couple of weeks there has been on a lot of chatter on the gloomy situation of telehealth companies. Teladoc’s stock is down >70% from its…
 • 
Nadav Shimoni
January 2022
2021 summary - the curtate version
A quick and dirty summary of 2021 and some future outlook for Israeli companies
 • 
Nadav Shimoni
December 2021
Prescription Digital Therapeutics
A tale of selling drugs with software margins
 • 
Nadav Shimoni
© 2023 Nadav Shimoni
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing